ArticleJournal for immunotherapy of cancer2021

Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation.

Shujuan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.